Acetic Acid 0.6%

Dilute acetic acid (0.6% v/v in sterile water) is a research-supply reconstitution diluent used for peptide research compounds that require a mildly acidic medium for solubilization and short-term stability. The standard 10 mL vial format is supplied alongside lyophilized peptide research preparations whose solubility and stability characteristics are documented to be improved in dilute-acid versus neutral aqueous diluent — most notably AOD9604, IGF-1 LR3, MGF, and PEG-MGF in the published peptide research-supply literature.

The 0.6% concentration corresponds to approximately 0.1 M acetic acid in water, producing a pH of approximately 2.9 in the reconstituted preparation. This is mildly acidic — substantially less acidic than gastric pH but well below neutral aqueous pH — and is sufficient to support solubility of peptides whose isoelectric points or specific structural characteristics make them poorly soluble in neutral aqueous bacteriostatic water.

This page is a research-only educational reference covering the chemistry, rationale, and research-context handling of dilute acetic acid as a peptide reconstitution diluent. The product is supplied for laboratory and research-supply use and is not intended for human consumption or any clinical application.

Acetic acid (CH3COOH, ethanoic acid, MW 60.05 g/mol) is a small simple carboxylic acid with a characteristic pungent odor. Pure glacial acetic acid is a liquid at room temperature (~17°C melting point) and is freely miscible with water. Aqueous solutions of acetic acid are widely used across chemistry and biology as a buffering and solvent system; common concentrations include 5% (table vinegar), 100% (glacial), and various dilute concentrations for specific applications.

The 0.6% v/v dilute acetic acid preparation corresponds to approximately 0.1 M acetic acid (acetic acid density ~1.05 g/mL, MW 60.05; 0.6 mL of glacial acid in 100 mL aqueous solution gives ~0.63 g acid in 100 mL, or ~0.105 M). The pKa of acetic acid is 4.76; at the resulting pH of approximately 2.9, the acetic acid is predominantly in the protonated (uncharged carboxylic-acid) form rather than the deprotonated (acetate anion) form. This is a mildly acidic medium suitable for peptides whose solubility is improved by protonation of acidic residues (aspartate, glutamate) and reduction of net negative charge.

The 10 mL volume supports reconstitution of multiple lyophilized peptide vials within an appropriate shelf-life period. Specific reconstitution-volume requirements vary by peptide; typical values are in the 1-3 mL range per lyophilized vial, so a single 10 mL acetic acid vial supports several reconstitution events.

The product is supplied as a research-supply reconstitution diluent for the research-supply peptide industry. It is not formulated or labeled for clinical or human use; it is a laboratory reagent for research-context reconstitution of research-grade peptide preparations.

Acetic acid is one of the oldest characterized organic compounds, with vinegar (5% aqueous acetic acid) representing one of the oldest preservative and food-acid traditions in human history (Egyptian and Roman use is documented). The compound is produced commercially by fermentation (Acetobacter species oxidation of ethanol) or by chemical synthesis (the modern Cativa process uses methanol carbonylation with rhodium or iridium catalysis). Pharmaceutical-grade and reagent-grade acetic acid is widely available at standard concentrations.

The use of dilute acetic acid as a peptide reconstitution diluent emerged from peptide chemistry and research-supply practice. Peptide chemists have long used dilute acetic acid (and related mildly acidic media including dilute hydrochloric acid, dilute trifluoroacetic acid, and dilute formic acid) as solubilization vehicles for peptides whose neutral-pH solubility is poor. The specific 0.6% concentration in the peptide research-supply context emerged as a standardized dilute-acid format providing sufficient acidity for the relevant peptide solubilization without being so acidic as to risk significant acid-catalyzed peptide degradation over typical handling timeframes.

The peptide research-supply industry has converged on a small set of standard reconstitution diluents: bacteriostatic water (0.9% benzyl alcohol in USP sterile water) for the majority of lyophilized peptide preparations, dilute acetic acid (0.6% in this format) for peptides requiring acid solubilization, and preservative-free sterile water for cell-culture or specific compatibility applications. The choice for any specific peptide is documented on the supplier's certificate of analysis and technical literature.

Peptide solubility in aqueous media depends on multiple factors: the amino-acid composition (the balance of charged, polar, and hydrophobic residues), the isoelectric point (pI) of the molecule, the secondary and tertiary structure of the folded peptide, the presence of free cysteine residues capable of disulfide-bond formation, and the specific aqueous-medium composition (pH, ionic strength, buffer composition). Some peptides are highly soluble across a wide pH range; others have narrow solubility windows and require specific pH or ionic-strength conditions for adequate dissolution.

Peptides whose pI is near neutral pH (between approximately 5 and 8) often show minimum solubility in neutral aqueous bacteriostatic water, because the molecule has near-zero net charge and tends to aggregate. Acidifying the medium below the pI shifts the molecule to a net positive charge state, increasing electrostatic repulsion between peptide molecules and improving solubility. The mildly acidic 0.6% acetic acid medium provides this pH shift while remaining well above pH ranges where acid-catalyzed peptide bond hydrolysis becomes a significant concern over typical reconstitution timeframes.

Specific peptides for which dilute acetic acid is the standard recommended reconstitution diluent include:

AOD9604. A fragment of human growth hormone (residues 177-191 with a tyrosine substitution at the N-terminus). The lipolytic-domain fragment has solubility characteristics that are improved in dilute acid versus neutral aqueous medium.

IGF-1 LR3. A long-arg3 modified analog of insulin-like growth factor 1, with a 13-residue N-terminal extension replacing the standard IGF-1 N-terminus and an arginine substitution at position 3 (eliminating IGFBP-3 binding). The molecule is well-soluble in dilute acid.

MGF (mechano-growth factor). The IGF-1 splice variant with a unique C-terminal extension. The IGF-family character produces solubility characteristics consistent with the broader IGF-1 family.

PEG-MGF. PEGylated MGF; the PEG conjugation modifies pharmacokinetic properties but the underlying IGF-family solubility characteristics motivate the dilute-acid reconstitution recommendation.

The choice of acetic acid specifically — rather than hydrochloric acid or other mineral acids — reflects the volatility of acetic acid (acetate can be removed by evaporation if subsequent analytical or biological applications require it), its low toxicity at the dilute concentrations used, its weak-acid character providing mild buffering behavior, and its compatibility with standard analytical methods (HPLC, mass spectrometry) commonly used in peptide research.

Reconstituted dilute-acid peptide solutions should be used promptly or stored briefly at refrigerated temperature; the dilute-acid medium does not provide bacteriostatic protection comparable to benzyl-alcohol-preserved bacteriostatic water, and prolonged storage of reconstituted material in dilute acid is not appropriate without specific stability data supporting it.

Composition of the 0.6% acetic acid research-supply preparation: - Acetic acid (glacial, ~99-100% w/v starting material), diluted to 0.6% v/v. - Sterile water vehicle. - Total volume: 10 mL per vial.

The aqueous solution has approximate molarity 0.1 M acetic acid (depending on the exact preparation specification), pH approximately 2.9, and no other excipients in the standard reagent-grade format.

The vial is typically a glass container with elastomeric closure compatible with needle entry. The 10 mL volume supports multiple reconstitution events within an appropriate shelf-life period.

Specifications appear on the supplier's certificate of analysis: acid concentration (acetic acid content), pH, sterility (if represented as sterile), endotoxin (if represented for parenteral-research compatibility), and visual appearance (clear and colorless). Pharmaceutical-grade glacial acetic acid is the typical starting material for research-supply preparations of this kind.

The principal research-supply application of dilute acetic acid is as a reconstitution diluent for lyophilized peptide preparations that require an acidic medium for solubilization and short-term stability:

AOD9604 reconstitution. AOD9604 lyophilized vials are reconstituted with dilute acetic acid following the supplier's documented reconstitution protocol. The dilute acid supports the peptide's solubility and short-term stability.

IGF-1 LR3 reconstitution. IGF-1 LR3 lyophilized vials are reconstituted with dilute acetic acid as the standard recommended diluent. The IGF-family character of the molecule motivates the acid-medium recommendation.

MGF reconstitution. Mechano-growth factor lyophilized vials are reconstituted with dilute acetic acid following the same IGF-family-derived recommendation.

PEG-MGF reconstitution. PEGylated MGF reconstitution similarly uses dilute acetic acid as the standard recommended diluent.

Other acid-soluble peptide preparations. Various other peptides in research-supply catalogs have specific recommendations for dilute-acid reconstitution based on their individual solubility characteristics; consult each specific preparation's certificate of analysis and technical literature for the recommended diluent.

Buffer preparation for analytical methods. Dilute acetic acid is also used as a mobile-phase or sample-buffer component in some HPLC and mass-spectrometric peptide analytical methods. The volatile acid is compatible with electrospray ionization mass spectrometry, supporting analytical applications that require acidic conditions without the non-volatile counterions of mineral-acid alternatives.

Cell-culture compatibility considerations. Dilute acetic acid is not the standard reconstitution diluent for cell-culture applications because the acidic pH would disrupt cell-culture medium pH if added in significant volume. For cell-culture applications, peptides reconstituted in dilute acid are typically diluted substantially into buffered cell-culture medium, where the buffer capacity of the medium restores physiological pH, before exposure to cells.

All applications are research-supply context: laboratory and research-supply use in reconstitution of research-grade peptide preparations and in analytical workflows. The preparation is not for human consumption. Nothing on this page describes a clinical protocol or therapeutic use.

Dilute acetic acid sits alongside bacteriostatic water and other reconstitution diluents in the research-supply peptide-handling toolkit.

Dilute acetic acid (0.6% v/v in sterile water, ~0.1 M, pH ~2.9) is a research-supply reconstitution diluent used for lyophilized peptide research preparations that require a mildly acidic medium for solubilization. The standard peptides reconstituted with this diluent in the research-supply industry include AOD9604, IGF-1 LR3, MGF, and PEG-MGF — preparations whose IGF-family character or other structural features produce limited solubility in neutral aqueous bacteriostatic water.

The mildly acidic medium shifts these peptides below their isoelectric points, producing a net positive charge that increases electrostatic repulsion and improves solubility. The pH (~2.9) is acidic enough for the solubilization effect but well above ranges where acid-catalyzed peptide bond hydrolysis becomes a significant concern over typical handling timeframes. The choice of acetic acid (rather than HCl or other mineral acids) reflects the volatility, low dilute-concentration toxicity, and analytical compatibility of the weak organic acid.

This 10 mL vial supports reconstitution of multiple lyophilized peptide vials within an appropriate shelf-life period. The product is supplied as a research-supply laboratory reagent for the research-context reconstitution of research-grade peptide preparations. It is not for human consumption and is not formulated or labeled for clinical use.